News
Company ImmuPharma PLC
TIDM IMM
Headline Annual Report and Accounts & Notice of AGM
Released 16:38 26-Apr-2011
Number 4857F16
FOR IMMEDIATE RELEASE
London, 26 April 2011
Annual Report and Accounts
Notice of Annual General Meeting: 19 May 2011
In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2010, has been posted to shareholders.
The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.
The Company's Annual General Meeting will be held on 19 May 2011 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.
For further information please contact:
ImmuPharma PLC +44 20 7152 4080
Dr Robert Zimmer, President
Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman
Buchanan Communications +44 20 7466 5000
Lisa Baderoon, Mark Court
Panmure Gordon & Co., NOMAD & Broker +44 20 7459 3600
Andrew Burnett,
Rakesh Sharma
Espirito Santo Investment Bank +44 20 7456 9191
James Bromhead, Richard Crawley
© London Stock Exchange plc. All rights reserved